Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,578 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07614191RecruitingEarly Phase 1
GT801 Cell Therapy for Hard-to-Treat Autoimmune Diseases
This early-stage study tests a new cell-based treatment called GT801 for autoimmune diseases that haven't responded well to standard medicines. It aims to see if this approach is safe and helps reduce symptoms in conditions like lupus, vasculitis, and scleroderma.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT07391813RecruitingPhase 1/Phase 2
Testing SNB-101 for advanced small cell lung cancer
This study tests a new drug, SNB-101, for people with small cell lung cancer that has spread and has worsened after standard therapy. It aims to find out if SNB-101 can help control the cancer and what side effects it may cause.
KamenitzAges 18 years+ - NCT07508488RecruitingPhase 2
Deucravacitinib for scarring hair loss (Phase 2)
This study tests an oral medication called deucravacitinib for people with scarring hair loss (frontal fibrosing alopecia or central centrifugal cicatricial alopecia). It aims to see if the drug can reduce inflammation and stop or slow hair loss.
New York, New YorkAges 18 years+ - NCT04944615Recruiting
IVUS-guided stent placement for blocked heart artery using longer guidance
This trial compares two ways to place a stent (a small mesh tube) for a completely blocked heart artery: using an IVUS camera inside the artery versus using a standard x-ray approach. It may help people get better heart outcomes by improving how accurately the stent is placed in long-term blockages.
BeijingAges 18 years+ - NCT04537689RecruitingPhase 4
Test ixekizumab and stopping it in plaque psoriasis
This study looks at how well ixekizumab (an injection medication) works for moderate-to-severe plaque psoriasis, and what happens when the treatment is withdrawn. It may help you learn whether stopping the medicine is safe and how skin disease outcomes change over time.
Outram ParkAges 22–90 - NCT07079098RecruitingPhase 1
Quick radiation for limited cancer spread
This trial tests a faster way to give radiation to people with a few spots of cancer that have spread. They use a special scan to plan treatment right away, so you may not need a separate planning visit.
Cleveland, OhioAges 18 years+ - NCT05352061Enrolling by invitation
HIV support program for people with mental health and life challenges
This study looks at how an HIV treatment and prevention program can be improved for people who have HIV plus psychosocial challenges, especially when HIV is not well controlled. You may be able to join if your HIV is recent and higher than target, and you fit one of the specific participant groups.
Miami, FloridaAges 18 years+ - NCT07510373Recruiting
Helping patients cut back on opioids after orthopedic surgery
This trial tests a program to help patients safely reduce their opioid pain relievers after leaving the hospital following orthopedic surgery. It is designed for people who are new to opioids and want to avoid long-term use.
The Bronx, New YorkAges 18 years+ - NCT07598578RecruitingEarly Phase 1
New drug combination for hard-to-treat T-cell lymphoma
This study tests a combination of three drugs (azacitidine, chidamide, and a PD-1 inhibitor) for T-cell lymphomas that have returned or stopped responding to previous treatment. The goal is to see if this combination can help shrink the cancer.
SuzhouAges 18–75 - NCT07605715Recruiting
Catheter vs. Surgery for Leaky Mitral Valve
This study compares two ways to fix a leaky mitral valve (a heart valve that doesn't close properly): one using a thin tube inserted through blood vessels (catheter) versus traditional open-heart surgery. The goal is to see which approach works better and is safer for older adults.
Los Angeles, CaliforniaAges 60 years+ - NCT07251413RecruitingPhase 1/Phase 2
Cemiplimab plus imiquimod and laser before surgery for basal cell carcinoma
This trial tests combining a skin cream (imiquimod), a laser treatment, and an immunotherapy drug (cemiplimab) before surgery for high-risk basal cell carcinoma. The goal is to see if this combination shrinks tumors enough to make surgery less disfiguring or damaging to nearby functions.
Barcelona, BarcelonaAges 18 years+ - NCT07613606Recruiting
Platelet-Rich Fibrin Injection for Gum Disease Treatment
This study tests a new injectable treatment using your own blood cells to help repair damaged gum tissue and bone around teeth affected by periodontal disease (gum disease). The goal is to see if this minimally invasive approach can regenerate healthy gum and bone without major surgery.
CairoAges 18 years+ - NCT06945705RecruitingPhase 2
Targeted therapy for EGFR-mutant lung cancer with brain spread
This trial tests a combination of two targeted pills (furmonertinib and anlotinib) as a first treatment for people with advanced EGFR-mutant non-small cell lung cancer that has spread to the brain. It aims to see if this combination works better than the standard approach for controlling the cancer.
ZhengzhouAges 18 years+ - NCT07625007Recruiting
Shortwave Therapy for Diabetic Nerve Pain
This trial tests a shortwave treatment to relieve pain and other nerve symptoms in people with diabetic peripheral neuropathy (nerve damage from diabetes). It is for adults who have not found enough relief from standard nerve medications.
ChongqingAges 18–85 - NCT07255391Enrolling by invitationPhase 4
Platelet-rich plasma for healing deep skin ulcers
This trial tests whether a treatment made from your own blood (platelet-rich plasma) can help heal deep skin ulcers (Grade III) that have been present for more than two weeks. It may be a good option if you have a normal platelet count and are not in palliative care.
L'Ametlla del Vallès, BarcelonaAges 18 years+ - NCT05304065RecruitingPhase 2
Safe program for suicidal thoughts or actions in youth
This Phase 2 study tests a safer way to support young people who recently had suicidal thoughts or acted on them. If you qualify, you may get the study treatment and support designed for teens and young adults after an urgent/emergency situation.
Los Angeles, CaliforniaAges 13–24 - NCT06864377Enrolling by invitation
Ventral Hernia Improvement of Treatment and Life
This study is testing a new way to treat and improve life with a ventral hernia (a hernia in the belly area). It's for people with an incisional hernia or a parastomal hernia.
KøgeAges 18 years+ - NCT05384496RecruitingPhase 2
Axitinib and nivolumab for advanced mucosal melanoma
This trial studies how well two medicines—axitinib and nivolumab—work for people with advanced melanoma that starts in moist “mucosal” areas (like the mouth, nose, throat, or bowel). It may help shrink tumors and control the disease by boosting the immune system and targeting tumor growth.
Harrison, New YorkAges 18 years+ - NCT07521943Recruiting
Hand Bone Fracture Treatment Study
This study tests the best way to treat certain broken bones in your hand (specifically in the middle section of bones that support your fingers). Researchers want to see if a newer treatment approach helps your hand heal better and work normally again.
Stockholm, Stockholm CountyAges 18 years+ - NCT05435794Recruiting
Long-term study of CPAP or a mouth guard for sleep apnea
This trial studies how CPAP (a breathing machine) or a custom mouth guard (MAD) affects sleep over the long term in people with obstructive sleep apnea. It may help confirm which treatment improves sleep and how well it works over time.
AngersAges 18–80 - NCT07524452RecruitingPhase 3
Becotatug vedotin plus immunotherapy for head and neck cancer
This trial tests a new combination of two drugs—becotatug vedotin (a targeted therapy) and a PD-1 inhibitor (an immunotherapy)—given before surgery to treat advanced head and neck squamous cell carcinoma. The goal is to shrink tumors and improve surgical outcomes for patients with specific cancer markers.
Zhuhai, GuangdongAges 18–75 - NCT06680401Recruiting
EHE: An Observational Study for People With This Rare Tumor
This study is tracking people with a rare blood vessel tumor called epithelioid hemangioendothelioma (EHE) to learn more about how it behaves and how best to care for you. By joining, you'll help doctors improve future treatments for this condition.
MilanAges 18 years+ - NCT06766578RecruitingPhase 2
Low-dose radiation plus immunotherapy and chemo before gastric cancer surgery
This trial tests a new combination of low-dose radiation, an immunotherapy drug (tirelizumab), and chemotherapy (SOX) given before surgery for locally advanced gastric or gastroesophageal junction cancer. The goal is to see if this approach can shrink tumors more effectively.
Jinan, ShandongAges 18–75 - NCT06764875RecruitingPhase 3
New drug combo for HER2-positive stomach cancer
This trial tests a new immunotherapy called rilvegostomig combined with standard chemotherapy and a targeted therapy (trastuzumab deruxtecan) for people with advanced HER2-positive stomach or gastroesophageal junction cancer that has not been treated before.
Anchorage, AlaskaAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,578 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.